BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...NASDAQ:EDIT) hired Gad Berdugo as CBO, a new position. He was co-founder and CEO of EpiVax Oncology Inc....
BioCentury | Mar 27, 2020
Product Development

March 26 Quick Takes: Pear’s digital therapeutic approved for insomnia; plus Medimetriks-Otsuka, Merck KGaA, Jazz, Roche, EpiVax

...to $190.5 million in milestones, plus royalties. EpiVax shortens time to produce personalized cancer vaccines EpiVax Oncology Inc....
BioCentury | Jan 29, 2020
Company News

Management tracks: Century Therapeutics, Passage, Forbion, Bavarian, Disc, Biocartis, QuantuMDx and more

...assay for detection and genotyping of high-risk HPV strains in early 2021. Cancer immunotherapy company EpiVax Oncology Inc....
BioCentury | Oct 23, 2018
Company News

Management tracks: Celgene, Seres, AC Immune

...of U.S. oncology strategy, partnering and operations at Novartis AG (NYSE:NVS; SIX:NOVN). Cancer immunotherapy company EpiVax Oncology Inc....
Items per page:
1 - 4 of 4
BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...NASDAQ:EDIT) hired Gad Berdugo as CBO, a new position. He was co-founder and CEO of EpiVax Oncology Inc....
BioCentury | Mar 27, 2020
Product Development

March 26 Quick Takes: Pear’s digital therapeutic approved for insomnia; plus Medimetriks-Otsuka, Merck KGaA, Jazz, Roche, EpiVax

...to $190.5 million in milestones, plus royalties. EpiVax shortens time to produce personalized cancer vaccines EpiVax Oncology Inc....
BioCentury | Jan 29, 2020
Company News

Management tracks: Century Therapeutics, Passage, Forbion, Bavarian, Disc, Biocartis, QuantuMDx and more

...assay for detection and genotyping of high-risk HPV strains in early 2021. Cancer immunotherapy company EpiVax Oncology Inc....
BioCentury | Oct 23, 2018
Company News

Management tracks: Celgene, Seres, AC Immune

...of U.S. oncology strategy, partnering and operations at Novartis AG (NYSE:NVS; SIX:NOVN). Cancer immunotherapy company EpiVax Oncology Inc....
Items per page:
1 - 4 of 4